Sylentis, S.A.U.
Contact
Address: Parque Tecnológico PCM C/Santiago Grisolía, 2
City: 28760 Tres Cantos
Province: Madrid
Phone: 34 91 804 76 67
sylentis@sylentis.com
http://www.sylentis.com
Mission and Objectives
Sylentis focuses on researching new therapeutic approaches based on gene silencing. Sylentis is specialised in developing therapies via interference RNA, a powerful tool for rational drug design.
Products/Services, Areas of interest for future collaborations/Alliances
We are developing treatments for glaucoma and dry eye syndrome. Sylentis is also focusing on inflammatory bowel disease. Furthermore, Sylentis is focusing on post-traumatic neuron lesions and ischaemia, neurodegenerative diseases and dementia.
AREAS OF INTEREST TO FUTURE COLLABORATIONS:
Because the release of RNAi in the body is an important part of these technologies, the company has a number of research projects under way regarding the controlled release of drugs, in cooperation with various public and private institutions.
Permalink  

 
Sylentis, S.A.U.
Developed by Web4Bio